SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014278
Filing Date
2024-04-11
Accepted
2024-04-11 08:00:32
Documents
17
Period of Report
2024-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40470
2 ex99-1.htm EX-99.1 934
3 ex99-2.htm EX-99.2 914
4 ex99-1_001.jpg GRAPHIC 732682
5 ex99-2_001.jpg GRAPHIC 646488
  Complete submission text file 0001493152-24-014278.txt   2117656

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20240411.xsd EX-101.SCH 3060
7 XBRL LABEL FILE pcsa-20240411_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE pcsa-20240411_pre.xml EX-101.PRE 22389
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3620
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 24837154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)